1. Home
  2. TRST vs PHAR Comparison

TRST vs PHAR Comparison

Compare TRST & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TrustCo Bank Corp NY

TRST

TrustCo Bank Corp NY

HOLD

Current Price

$42.43

Market Cap

699.3M

Sector

Finance

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$18.13

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRST
PHAR
Founded
1902
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
699.3M
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TRST
PHAR
Price
$42.43
$18.13
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$38.00
AVG Volume (30 Days)
123.0K
24.5K
Earning Date
01-20-2026
11-06-2025
Dividend Yield
3.57%
N/A
EPS Growth
21.05
N/A
EPS
3.00
0.00
Revenue
$181,464,000.00
$362,274,000.00
Revenue This Year
$13.13
$25.19
Revenue Next Year
N/A
$4.47
P/E Ratio
$14.18
$3,041.40
Revenue Growth
7.63
26.78
52 Week Low
$27.18
$7.50
52 Week High
$45.27
$18.30

Technical Indicators

Market Signals
Indicator
TRST
PHAR
Relative Strength Index (RSI) 47.79 49.29
Support Level $42.29 $16.98
Resistance Level $44.50 $18.30
Average True Range (ATR) 1.08 0.72
MACD -0.34 -0.04
Stochastic Oscillator 6.74 25.17

Price Performance

Historical Comparison
TRST
PHAR

About TRST TrustCo Bank Corp NY

Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: